Did an Alzheimer's drug give Sue and Ken Bell more time? MaybeLeqembi and Kisunla, new Alzheimer's drugs, can slow disease progression but do not restore memory or cognition.
FDA Approves Second Alzheimer's Drug That Can Modestly Slow DiseaseFDA approved Kisunla, a new Alzheimer's drug that slows cognitive decline modestly for early-stage patients.
FDA approves a second Alzheimer's drug that can modestly slow diseaseA new Alzheimer's drug approved by U.S. officials can modestly slow the disease, offering a new option for early-stage patients.
New Drug Approved for Early Alzheimer'sThe FDA approved a new drug for Alzheimer's disease, Donanemab (Kisunla), shown to slow cognitive decline in early stages with significant safety risks.
FDA Approves Second Alzheimer's Drug That Can Modestly Slow DiseaseFDA approved Kisunla, a new Alzheimer's drug that slows cognitive decline modestly for early-stage patients.
FDA approves a second Alzheimer's drug that can modestly slow diseaseA new Alzheimer's drug approved by U.S. officials can modestly slow the disease, offering a new option for early-stage patients.
New Drug Approved for Early Alzheimer'sThe FDA approved a new drug for Alzheimer's disease, Donanemab (Kisunla), shown to slow cognitive decline in early stages with significant safety risks.
New Drug Approved for Early Alzheimer'sFDA approved new Alzheimer's drug Kisunla by Eli Lilly, showing potential cognitive decline slowing and unique stoppage after amyloid clearance.